Discovery helps to spot what makes a good drug
A new test developed by researchers from the University of Manchester could revolutionize the discovery of new prescription drugs.
2014-10-02
(Press-News.org) A new test developed by researchers from the University of Manchester could revolutionise the discovery of new prescription drugs. The test will help determine which drugs are unlikely to work at an early stage, speeding up the time it takes to make safe and effective medicines available. The findings are published online in the journal Metabolomics.
The Pharmaceuticals industry is worth billions of dollars a year. The main source of prescription medicines comes from what are known as 'small molecule' drugs, such as statins and antibiotics.
The main problem for those who would benefit from new medicines, and for the industry, is that most new small molecule drugs never make it out of the door of the drug companies, because – despite early promise – they either do not work or because they show toxicity. Known as 'attrition', this is bad for patients and extremely costly for the pharmaceutical industry and it would help a lot if we could find a rule that most drugs obeyed.
A famous test, colloquially called the 'rule of 5', was developed by Chris Lipinski and colleagues from Pfizer in 1997. The rule sets down four properties that a synthetic i.e. man-made molecule should obey if it is to have a chance of becoming a successful drug. However, the rule doesn't normally work for naturally-occurring products, that is, drugs with active ingredients that come from nature (penicillin, for example, which is produced by Penicillium fungi). Nearly half of new drugs are based on naturally-occurring substances.
In 2013, researchers at The University of Manchester helped create a ground-breaking computer model that replicates how the human metabolic network works. A kind of 'instruction manual' for how our metabolism interacts with human diseases, this model means scientists now know most of the small molecules that are used by our bodies as part of our normal biochemistry.
Armed with this knowledge, the University's research team, led by Professor Douglas Kell of its School of Chemistry and the Manchester Institute of Biotechnology, compared the structures of all these molecules, known as metabolites, with all marketed drugs (including natural products). They also compared drugs and metabolites with synthetic chemicals from a commercial Maybridge chemical library.
Professor Kell said, "We immediately saw a very strong correlation. More than 90% of marketed drugs - and we tested over 1300 of the FDA's (Food and Drug Administration) approved drugs - bear a structural similarity of at least 0.5 to at least one metabolite. In other words, they look very like them. This new 'rule of 0.5' does not mean that a molecule obeying it will necessarily become a successful drug, but what it does mean is that we can now say that a molecule that does not obey it, is very unlikely to succeed."
This new finding should be of considerable value in avoiding the costly problems of attrition, freeing up more resources for developing effective medicines and making them available more quickly for those who need them.
INFORMATION:
Notes for editors
The scientists' findings, A 'rule of 0.5' for the metabolite-likeness of approved pharmaceutical drugs by O'Hagan, N. Swainston, J. Handl, & D. B. Kell (2014) are published in the journal Metabolomics
http://link.springer.com/article/10.1007/s11306-014-0733-z
The research was supported by the Biotechnology and Biological Sciences Research Council and the University of Manchester.
More information about Maybridge chemical libraries is available at http://www.maybridge.com..
More information about the computer model that replicates the human metabolic network can be found here http://www.manchester.ac.uk/discover/news/article/?id=9642
Media enquiries to:
Katie Brewin
Media Relations Officer
The University of Manchester
Tel: 0161 275 8387
Email: Katie.brewin@manchester.ac.uk
ELSE PRESS RELEASES FROM THIS DATE:
2014-10-02
AUDIO:
These are gray snapper larval growls recorded in the field.
Click here for more information.
MIAMI – A new study from researchers at the University of Miami (UM) Rosenstiel School of Marine and Atmospheric Science is the first to document that fish larvae produce sound. These "knock" and "growl" sounds may help small larvae maintain group cohesion in the dark.
"Although many adult fishes produce sounds, no one has previously considered that larvae, too, may be sound ...
2014-10-02
For decades, research has generally focused on individual, family and peer factors to explain illicit drug use, neglecting neighborhood factors as a cause. While the scant previous research on neighborhood factors and illicit drug use has focused on facets such as crime and socio-demographic characteristics, none has explored the associations between the perceived frequency of drug sales, drug use, and peer attitudes towards drug use. Now a study out of New York University's Center for Drug Use and HIV Research (CDUHR), address this paucity in the research.
Published ...
2014-10-02
Schizophrenia and bipolar disorder both appear to be associated with dendritic spine loss in the brain, suggesting the two distinct disorders may share common pathophysiological features, write author Glenn T. Konopaske, M.D., and colleagues at McLean Hospital, Belmont, Mass., and Harvard Medical School, Boston.
The dendritic spines play a role in a variety of brain functions. Previous studies have observed spine loss in the dorsolateral prefrontal cortices (DLPFCs) from individuals with schizophrenia (SZ). To determine whether spine pathology happens in individuals with ...
2014-10-02
EAST LANSING, Mich. --- New research suggests dear old Mom and Dad could be the auto industry's secret weapon.
The study, co-authored by Michigan State University economist Soren Anderson, found children are 39 percent more likely to buy a particular brand of automobile if their parents bought that brand.
This surprisingly strong correlation could have implications for automakers' marketing efforts. In absence of this inherited brand loyalty, a sensible strategy might be to "invest in young consumers and harvest old consumers" – that is, lower prices on entry-level ...
2014-10-02
A group of researchers from Switzerland has thrown light on the precise mechanisms responsible for the impressive ability of nanoparticles to detect fingermarks left at crime scenes.
Publishing their results today, 2 October, in IOP Publishing's journal Nanotechnology, the researchers have provided evidence contesting the commonly accepted theory that nanoparticles are attracted to fingermarks electrostatically.
The attraction, they claim, is in fact chemical and is caused by compounds on the surface of nanoparticles bonding with a complex cocktail of compounds present ...
2014-10-02
People who are prone to delusions gather insufficient information before making decisions, according to research published in the journal Psychological Medicine.
Researchers from Royal Holloway, University of London, led by PhD student Leslie van der Leer, assigned participants a computer task in which they observed the colour of a black or white fish caught from one of two lakes and were then asked to choose to see further fish or decide on one of the lakes as the source of that sequence of fish.
Each participant was rewarded for choosing the correct lake but costs ...
2014-10-02
Recruiting health workers with high levels of internal motivation is critical for work in difficult conditions, where their personal security and health might be compromised, according to new research published today in Health Policy and Planning.
Health workers often witness the deaths of friends and colleagues during conflict situations and also face abduction, injury and death, themselves. Life history interviews with 26 health workers who lived through conflict in Northern Uganda reveal their resilience and how they coped by building trusting relationships with the ...
2014-10-02
A unique collection of studies exploring the theme of the Third Global Symposium on Health Systems Research has been published today in a supplement to Health Policy and Planning.
This collection of studies on 'the science and practice of people-centred health systems' presents the latest in the field of health policy and systems research, bringing together research from Ethiopia, Uganda, Ghana, Nigeria, South Africa, India, Argentina and Brazil. The eleven studies comprising the supplement employ a range of methods to investigate different aspects of people-centred health ...
2014-10-02
Some sharks are 'gregarious' and have strong social connections, whilst others are more solitary and prefer to remain inconspicuous, according to a new study which is the first to show that the notorious predators have personality traits.
Personalities are known to exist in many animals, but are usually defined by individual characteristics such as how exploratory, bold or aggressive an individual is.
Research led by the University of Exeter and the Marine Biological Association of the UK (MBA) has shown for the first time that individual sharks actually possess social ...
2014-10-02
Evolocumab, an injected form of a new class of drugs called PCSK9 inhibitors[1], is highly effective at reducing low-density lipoprotein (LDL) or "bad cholesterol" levels with few side effects in people with familial hypercholesterolaemia (FH), an inherited condition that causes extremely high cholesterol and high risk of cardiovascular disease at an early age.
Published in The Lancet, the results of two of the largest global randomised trials ever undertaken in this field found that evolocumab rapidly cut levels of LDL cholesterol by on average 60% more than those given ...
LAST 30 PRESS RELEASES:
[Press-News.org] Discovery helps to spot what makes a good drug
A new test developed by researchers from the University of Manchester could revolutionize the discovery of new prescription drugs.
